Islet transplantation in the discordant tilapia-to-mouse model: a novel application of alginate microencapsulation in the study of xenograft rejection
- 15 March 2003
- journal article
- research article
- Published by Wolters Kluwer Health in Transplantation
- Vol. 75 (5), 599-606
- https://doi.org/10.1097/01.tp.0000048226.28357.0d
Abstract
Background. Tilapia islet xenograft rejection is characterized by infiltration with macrophages (Mφs), eosinophils (Eφs), and T lymphocytes. The presence of these cells indicates they contribute to rejection; therefore, an attempt was made to assess their role through host immunomodulation. Methods. Tilapia islet cells were transplanted under the kidney capsule of streptozotocin diabetic Balb/c mice, which were then treated with one of several immunomodulatory regimes targeting Mφs, Eφs, or T cells. Mφs were depleted using either silica or liposome-entrapped Cl2MDP. Eφ migration was blocked using monoclonal antibodies (mAbs) targeting interleukin (IL)-4 or IL-5. T-cell function was altered with mAbs targeting CD3, CD4, or CD8. Finally, T helper (Th)1 and Th2 activity was altered by depleting essential Th1 or Th2 cytokines with mAbs or by promoting a Th1 response with the injection of exogenous IL-12. The effects of antibody-mediated immunomodulation on graft survival were initially screened by cotransplanting alginate-encapsulated, mAb-secreting hybridoma cells into the peritoneal cavity at the time of islet transplantation. Significant prolongation was then confirmed using purified antibodies injected at the time of islet transplantation. Rejected grafts were examined histologically, and immunohistochemistry was used to assess the cellular infiltrates for each of the treatment groups. Results. Modulation of Mφs and Eφs alone did not significantly delay functional rejection of tilapia islet grafts (maximal mean graft survival time [mGST]=7.1±1.7 and 9.4±3.4, respectively) compared with untreated controls (mGST=8.2±1.0). Treatment of transplanted animals with antibodies against CD3 or CD4 significantly promoted graft survival (maximal mGST=16.3±5.8 and 34.0±11.6, respectively), whereas targeting CD8 and Th1 and Th2 cytokines showed no prolonging effect (maximal mGST=7.8±2.9 and 9.5±4.3, respectively). Conclusion. Our results indicate that rejection in the tilapia-to-mouse model follows a pattern similar to other models of discordant islet cell xenotransplantation.Keywords
This publication has 31 references indexed in Scilit:
- Expression of both Th1 and Th2 cytokines correlates with the histological rejection of MHC‐matched and MHC‐mismatched foetal pancreas allografts in miceImmunology & Cell Biology, 1997
- XENOGRAFT REJECTION OF PORCINE ISLET-LIKE CELL CLUSTERS IN NORMAL AND NATURAL KILLER CELL-DEPLETED MICE1Transplantation, 1996
- DONOR ANTIGEN-PRESENTING CELL–INDEPENDENT REJECTION OF ISLET XENOGRAFTSTransplantation, 1995
- The effect of a depleting anti-CD4 monoclonal antibody on T cells and fetal pig islet xenograft survival in various strains of miceTransplant Immunology, 1995
- SUPPRESSION OF SKIN ALLOGRAFT REJECTION IN MICE BY ANTI-CD3 MONOCLONAL ANTIBODIES WITHOUT CYTOKINE-RELATED SIDE-EFFECTS1Transplantation, 1994
- Depletion of CD4 Cells in Mice with Intraperitoneal Injection of Alginate-Encapsulated GK 1.5 Hybridoma Cells: A Potential Use in Development of Animal Models for Infectious DiseasesThe Journal of Infectious Diseases, 1993
- CD4-mediated stimulation of human eosinophils: lymphocyte chemoattractant factor and other CD4-binding ligands elicit eosinophil migration.The Journal of Experimental Medicine, 1991
- Transfer of diabetes in mice prevented by blockade of adhesion-promoting receptor on macrophagesNature, 1990
- EFFECT OF TRANSPLANTATION SITE AND αL3T4 TREATMENT ON SURVIVAL OF RAT, HAMSTER, AND RABBIT ISLET XENOGRAFTS IN MICETransplantation, 1989
- Prolongation of Islet Xenograft Survival Without Continuous ImmunosuppressionScience, 1980